Eric T. Wittbrodt PharmD, MPH

Eric passionate about Health economics and outcomes in chronic diseases, and Communication of the economic and clinical value of pharmacotherapy to key external stakeholders, and the Generation of real-world evidence to support the value proposition of pharmacotherapy. He is Scientific expertise in metabolic disease (DM, obesity), GI disorders, rheumatology, PK/PD, clinical trial design, biostatistics, and field epidemiology. Previous he has clinical and instructional (didactic and small group) experience in critical care, nephrology (including fluid, electrolyte, and acid-base), toxicology, and pulmonary therapeutics.